Advanced Instruments (Patricia Industries) Completes Acquisition of Nova Biomedical
March 19, 2025
Advanced Instruments, a wholly owned subsidiary of Patricia Industries, completed its acquisition of Nova Biomedical for an enterprise value of USD 2.2 billion. The transaction followed regulatory approval and resulted in the combined business operating under the Nova Biomedical name, led by Advanced Instruments’ CEO Byron Selman.
- Buyers
- Advanced Instruments, Patricia Industries
- Targets
- Nova Biomedical
- Sellers
- Nova Biomedical founding shareholders (Frank Manganaro and Dr. Chung-Chang Young)
- Platforms
- Advanced Instruments
- Industry
- Healthcare Services
- Location
- Massachusetts, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Isto Biologics Acquires NovaBone Products LLC
August 4, 2026
Healthcare Services
Isto Biologics announced the acquisition of NovaBone Products LLC, a developer and manufacturer of synthetic bone graft products, from Halma plc. The deal, supported by Keensight Capital, adds NovaBone’s bioactive glass technologies to Isto’s bone graft substitutes platform and expands its geographic reach and surgical end-market presence.
-
Aspen Medical Products Acquires Advanced Orthopaedics
January 29, 2025
Medical Devices
Aspen Medical Products, the Irvine-based spinal orthopedics manufacturer, has acquired Advanced Orthopaedics, a manufacturer and supplier of bracing solutions and orthopedic soft goods. The acquisition expands Aspen’s product portfolio into the bracing and supports market and is intended to strengthen service to distributors, hospitals, DME suppliers and retail partners while enhancing Aspen’s global reach.
-
Advanced Instruments Acquires Artel
April 26, 2022
Medical Devices
Advanced Instruments has signed an agreement to acquire Artel, a Westbrook, Maine-based provider of calibration and validation instruments, consumables, software and services for life-science laboratories. The add-on transaction is funded by Patricia Industries and Advanced Instruments (with external debt), values Artel at an upfront ~$85m with contingent payments of up to $55m, and is intended to expand Advanced Instruments' liquid-handling portfolio and R&D capabilities.
-
Advanced Instruments Acquires Solentim
August 5, 2021
Medical Devices
Advanced Instruments has signed a definitive agreement to acquire Solentim for approximately USD 240 million, in a strategic add-on funded mainly with equity from Patricia Industries. The acquisition expands Advanced Instruments' bioprocessing instruments and consumables portfolio and combines complementary imaging, automation and single-cell cloning capabilities; Solentim is headquartered in Bournemouth, United Kingdom, and reported ~USD 17m revenue and ~USD 5m adjusted EBITDA for the 12 months to June 2021.
-
Patricia Industries Acquires Advanced Instruments
September 28, 2020
Medical Devices
Patricia Industries, part of Investor AB, has completed the acquisition of US-based Advanced Instruments, a global leader in osmolality testing instrumentation and consumables, from Windjammer Capital. The deal values Advanced Instruments at an enterprise value of USD 780 million; Patricia Industries injected roughly USD 619–620 million of equity for majority ownership. Advanced Instruments (headquartered in Norwood, Massachusetts) serves clinical, biopharmaceutical and food & beverage markets and reported approximately USD 72 million in sales for the 12 months ending June 30, 2020.
-
Patricia Industries (Investor AB) Acquires Advanced Instruments from Windjammer Capital
September 1, 2020
Medical Devices
Patricia Industries, part of Investor AB, has signed an agreement to acquire Advanced Instruments, LLC from Windjammer Capital for an enterprise value of $780 million. Advanced Instruments, headquartered in Norwood, Massachusetts, is a manufacturer of scientific and analytical instruments serving the clinical, biotechnology and food & beverage markets; the transaction is expected to close in Q4 2020 subject to regulatory approvals.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.